|
Diabetes, Vol 48, Issue 4 903-908, Copyright © 1999 by American Diabetes Association
Pivotal role of nitric oxide in the control of blood pressure after leptin administration
G Fruhbeck
Department of Endocrinology, Clinica Universitaria de Navarra, University of Navarra, Pamplona, Spain. gfruhbeck@unav.es
Leptin administration has been shown to increase renal, adrenal, and lumbar
sympathetic nerve activity. However, this generalized sympathoexcitatory
activity is not always followed by an increase in arterial pressure. The
present study tested the hypothesis that leptin induces a release of nitric
oxide (NO) that opposes the pressor effect of sympathoexcitation. The
effect of intravenous administration of leptin (10, 100, and 1,000
microg/kg body wt) or vehicle on blood pressure (BP), heart rate (HR), and
serum nitrite/nitrate concentrations of anesthetized Wistar rats was
examined. At 90 min after injection, the three leptin doses tested
increased serum NO concentrations 20.5, 33.1, and 89.5%, respectively (P
< 0.001 vs. baseline). The effect of leptin on NO concentrations was
significantly dose-dependent on linear trend testing (P = 0.0001). In
contrast, leptin did not change serum nitrite/nitrate concentrations of
fa/fa rats. Leptin administration to Wistar rats under NO synthesis
inhibition (N(omega)-nitro-L-arginine methyl ester [L-NAME]) produced a
statistically significant increase (P < 0.05) in both systolic BP and
mean arterial pressure as well as in HR (P < 0.01). Injection of leptin
into rats with pharmacologically induced ganglionic blockade
(chlorisondamine) was followed by a decrease in BP and HR to values
significantly lower (P < 0.01) than those observed with chlorisondamine
treatment alone. The leptin-induced hypotension observed in the setting of
ganglionic blockade was blocked by L-NAME. These findings raise the
possibility that the leptin-induced release of NO may contribute to the
homeostasis of BP.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Yang and L. A. Barouch
Leptin Signaling and Obesity: Cardiovascular Consequences
Circ. Res.,
September 14, 2007;
101(6):
545 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Katagiri, T. Yamada, and Y. Oka
Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals
Circ. Res.,
July 6, 2007;
101(1):
27 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine,
June 1, 2007;
232(6):
727 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rodriguez, A. Fortuno, J. Gomez-Ambrosi, G. Zalba, J. Diez, and G. Fruhbeck
The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism
Endocrinology,
January 1, 2007;
148(1):
324 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Galvez, J. de Castro, D. Herold, G. Dubrovska, S. Arribas, M. C. Gonzalez, I. Aranguez, F. C. Luft, M. P. Ramos, M. Gollasch, et al.
Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2006;
26(6):
1297 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Stein, E. Vasquez-Garibay, J. Kratzsch, E. Romero-Velarde, and G. Jahreis
Influence of Nutritional Recovery on the Leptin Axis in Severely Malnourished Children
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
1021 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Thule, A. G. Campbell, D. J. Kleinhenz, D. E. Olson, J. J. Boutwell, R. L. Sutliff, and C. M. Hart
Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E114 - E122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G Haynes
Role of leptin in obesity-related hypertension
Exp Physiol,
September 1, 2005;
90(5):
683 - 688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Knudson, U. D. Dincer, C. Zhang, A. N. Swafford Jr., R. Koshida, A. Picchi, M. Focardi, G. M. Dick, and J. D. Tune
Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction
Am J Physiol Heart Circ Physiol,
July 1, 2005;
289(1):
H48 - H56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Minhas, S. A. Khan, S. V. Y. Raju, A. C. Phan, D. R. Gonzalez, M. W. Skaf, K. Lee, A. D. Tejani, A. P. Saliaris, L. A. Barouch, et al.
Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy
J. Physiol.,
June 1, 2005;
565(2):
463 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-F. Huang, B. Wang, X.-F. Yang, Q. Luo, and J.-Z. Sheng
Nitric Oxide Mediates Inhibitory Effect of Leptin on Insulin-Like Growth Factor I Augmentation of 17{beta}-Estradiol Production in Human Granulosa Cells
Biol Reprod,
January 1, 2005;
72(1):
102 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Fernandez-Alfonso
Regulation of Vascular Tone: The Fat Connection
Hypertension,
September 1, 2004;
44(3):
255 - 256.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers
Hypertension and Obesity
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
169 - 205.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Rahmouni and W. G. Haynes
Leptin and the Cardiovascular System
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
225 - 244.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Werner and G. Nickenig
From Fat Fighter to Risk Factor: The Zigzag Trek of Leptin
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
7 - 9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. D. Dixit, M. Mielenz, D. D. Taub, and N. Parvizi
Leptin Induces Growth Hormone Secretion from Peripheral Blood Mononuclear Cells via a Protein Kinase C- and Nitric Oxide-Dependent Mechanism
Endocrinology,
December 1, 2003;
144(12):
5595 - 5603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sader, M. Nian, and P. Liu
Leptin: A Novel Link Between Obesity, Diabetes, Cardiovascular Risk, and Ventricular Hypertrophy
Circulation,
August 12, 2003;
108(6):
644 - 646.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shirasaka, M. Takasaki, and H. Kannan
Cardiovascular effects of leptin and orexins
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2003;
284(3):
R639 - R651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.A Glader, L.S Birgander, S Soderberg, H.P Ildgruben, P Saikku, A Waldenstrom, and G.H Dahlen
Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis
Eur. Heart J.,
January 2, 2003;
24(2):
198 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fortuno, A. Rodriguez, J. Gomez-Ambrosi, P. Muniz, J. Salvador, J. Diez, and G. Fruhbeck
Leptin Inhibits Angiotensin II-Induced Intracellular Calcium Increase and Vasoconstriction in the Rat Aorta
Endocrinology,
September 1, 2002;
143(9):
3555 - 3560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Mastronardi, W. H. Yu, and S. M. McCann
Resting and circadian release of nitric oxide is controlled by leptin in male rats
PNAS,
April 16, 2002;
99(8):
5721 - 5726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Carlyle, O. B. Jones, J. J. Kuo, and J. E. Hall
Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Hypertension,
February 1, 2002;
39(2):
496 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vecchione, A. Maffei, S. Colella, A. Aretini, R. Poulet, G. Frati, M. T. Gentile, L. Fratta, V. Trimarco, B. Trimarco, et al.
Leptin Effect on Endothelial Nitric Oxide Is Mediated Through Akt-Endothelial Nitric Oxide Synthase Phosphorylation Pathway
Diabetes,
January 1, 2002;
51(1):
168 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Wold, D. P. Relling, J. Duan, F. L. Norby, and J. Ren
Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous Hypertension: Role of JAK/STAT Pathway
Hypertension,
January 1, 2002;
39(1):
69 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Mitchell, D. A. Morgan, M. L.G. Correia, A. L. Mark, W. I. Sivitz, and W. G. Haynes
Does Leptin Stimulate Nitric Oxide to Oppose the Effects of Sympathetic Activation?
Hypertension,
November 1, 2001;
38(5):
1081 - 1086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fruhbeck, J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
Am J Physiol Endocrinol Metab,
June 1, 2001;
280(6):
E827 - E847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. G. Correia, D. A. Morgan, W. I. Sivitz, A. L. Mark, and W. G. Haynes
Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure
Hypertension,
March 1, 2001;
37(3):
936 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shiuchi, H. Nakagami, M. Iwai, Y. Takeda, T.-X. Cui, R. Chen, Y. Minokoshi, and M. Horiuchi
Involvement of Bradykinin and Nitric Oxide in Leptin-Mediated Glucose Uptake in Skeletal Muscle
Endocrinology,
February 1, 2001;
142(2):
608 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. FRUHBECK, J. GOMEZ-AMBROSI, and J. SALVADOR
Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes
FASEB J,
February 1, 2001;
15(2):
333 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Kuo, O. B. Jones, and J. E. Hall
Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin
Hypertension,
February 1, 2001;
37(2):
670 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Winters, Z. Mo, E. Brooks-Asplund, S. Kim, A. Shoukas, D. Li, D. Nyhan, and D. E. Berkowitz
Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lepob) mice
J Appl Physiol,
December 1, 2000;
89(6):
2382 - 2390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Nickola, L. E. Wold, P. B. Colligan, G.-J. Wang, W. K. Samson, and J. Ren
Leptin Attenuates Cardiac Contraction in Rat Ventricular Myocytes : Role of NO
Hypertension,
October 1, 2000;
36(4):
501 - 505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Uckaya, M. Ozata, A. Sonmez, C. Kinalp, T. Eyileten, N. Bingol, B. Koc, F. Kocabalkan, and I. C. Ozdemir
Is Leptin Associated with Hypertensive Retinopathy?
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
683 - 687.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|